Azathioprine in multiple sclerosisβA 3 y
β
U. Patzold; P. Pocklington
π
Article
π
1980
π
Springer
π
English
β 895 KB
The results of a prospective, long-term controlled study on the treatment of multiple sclerosis with azathioprine are reported. The effect of a daily 2 mg/kg body weight dosage on 56 randomly chosen patients with multiple sclerosis is compared with a non-treated control group of 51 randomly selected